Case Timeline Item
Amgen, Inc. and Horizon Therapeutics plc, In the Matter of (timeline item) - December 14, 2023
Date
File
Decision and Order (Public Version)
(4.57 MB)
Displaying 481 - 500 of 36793
December 14, 2023
Case Timeline Item
Microsoft/Activision Blizzard, In the Matter of (timeline item) - December 14, 2023
Date
File
Joint Motion for Third Revised Scheduling Order
(762.12 KB)
Case Timeline Item
Luis Jorge Perez, In the Matter of (timeline item) - December 14, 2023
Date
File
Order Setting Briefing Schedule
(734.65 KB)
December 13, 2023
Statement Regarding the Termination of Sanofi’s Proposed Acquisition of Maze Therapeutics’ Pompe Disease Drug
Date
Following Sanofi’s decision to terminate its proposed acquisition of an exclusive license to Maze Therapeutics Inc.’s developmental drug to treat Pompe disease, the Federal Trade Commission moved to...
Case Timeline Item
Sanofi/Maze Therapeutics, Inc., In the Matter of (timeline item) - December 13, 2023
Date
File
Joint Motion to Dismiss Complaint
(1.55 MB)
December 12, 2023
La FTC anuncia una nueva regla para combatir las estafas en la compra de vehículos
Date
La Comisión Federal de Comercio (FTC, por su sigla en inglés) ha concluido una nueva regla para luchar contra dos tipos comunes de tácticas ilegales a las que se enfrentan los consumidores al comprar...
FTC Announces CARS Rule to Fight Scams in Vehicle Shopping
Date
The Federal Trade Commission has finalized a new rule to fight two common types of illegal tactics consumers face when buying a car: bait-and-switch tactics and hidden junk fees. The new rule is...
Case Timeline Item
Sanofi/Maze Therapeutics, Inc., In the Matter of (timeline item) - December 12, 2023
Date
File
Notice of Appearance - J. Weingarten
(886.89 KB)
Case Timeline Item
John Muir Health/Tenet Healthcare Co., In the Matter of (timeline item) - December 12, 2023
Date
File
Notice of Appearance - N. Miller
(885.82 KB)
December 11, 2023
FTC Seeks to Block Sanofi’s Acquisition of Rare Disease Drug that Threatens Sanofi’s Monopoly
Date
The Federal Trade Commission is seeking to block Sanofi’s proposed acquisition of an exclusive license to Maze Therapeutics Inc.’s therapy in development for treatment of Pompe disease. The Commission...
FTC Acts Against Operators of Income Scheme “The Sales Mentor” That Charged Consumers Millions for Bogus Telemarketing Advice
Date
The Federal Trade Commission has obtained proposed orders against the operators of a wide-ranging scheme known as “The Sales Mentor” that made millions by falsely promising consumers that they could...
Case Timeline Item
Intuit Inc., In the Matter of (TurboTax) (timeline item) - December 11, 2023
Date
File
Case Timeline Item
Sanofi/Maze Therapeutics, Inc., In the Matter of (timeline item) - December 11, 2023
Date
File
Administrative Complaint
(2.27 MB)
December 8, 2023
FTC Approves 2023 Budget for Horseracing Integrity and Safety Authority
Date
The Federal Trade Commission has issued an order approving the Horseracing Integrity and Safety Authority’s 2023 budget as submitted to the Commission. On March 27, 2023, the Commission adopted...
Federal Register Notice
Negative Option Rule; Notice of Informal Hearing and Request for Submissions
Date
Case Timeline Item
John Muir Health/Tenet Healthcare Co., In the Matter of (timeline item) - December 8, 2023
Date
File
Joint Motion to Continue Scheduling Conference
(744.65 KB)
December 7, 2023
FTC, DOJ and HHS Work to Lower Health Care and Drug Costs, Promote Competition to Benefit Patients, Health Care Workers
Date
Anticompetitive acquisitions and practices can chill fair competition, leading to higher health care costs, degraded working conditions, and less innovation across the health care and pharmaceutical...
Displaying 481 - 500 of 36793